Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Subsoil Management Techniques
1994
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
RNAscope
2011 Standout
Preclinical and Clinical Pharmacology of Vinca Alkaloids
1992
The Value and Complications of Percutaneous Transthoracic Lung Aspiration for the Etiologic Diagnosis of Community-Acquired Pneumonia
1999
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Bone marrow angiogenesis and progression in multiple myeloma
1994
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
1994 Standout
Clinical translation of angiogenesis inhibitors
2002 Standout
Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat
1990
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Drug development from marine natural products
2008 Standout
Bone marrow autotransplantation
1989
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus
2003
Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen.
1988
Vincristine revisited
1999
Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.
1988
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
1991
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Analysis of anticancer drugs: A review
2011 Standout
Interferon-alpha for induction and maintenance in multiple myeloma: Results of two multicenter randomized trials and summary of other studies
1995
Microtubules as a target for anticancer drugs
2004 Standout
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
1989 StandoutNobel
The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation.
1995
Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies
2011
Detection and determination of the major metabolites of [3H]cytosine arabinoside by high-performance liquid chromatography
1996
Automated Colorimetric In Situ Hybridization (CISH) Detection of Immunoglobulin (Ig) Light Chain mRNA Expression in Plasma Cell (PC) Dyscrasias and Non-Hodgkin Lymphoma
2003
Occupational exposure to antineoplastic agents at several departments in a hospital
1992 Standout
Late effects of childhood cancer therapy
2002
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Cancer of the Ovary
2004 Standout
Allogeneic bone marrow transplantation in a patient with acute myeloid leukemia secondary to Hodgkin's disease
1984
Oxidative inactivation of leukotriene C 4 by stimulated human polymorphonuclear leukocytes
1982 StandoutNobel
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Risk of Acute Nonlymphocytic Leukemia and Preleukemia in Patients Treated with Cyclophosphamide for Non-Hodgkin's Lymphomas
1985
Childhood and adolescent cancer statistics, 2014
2014 Standout
Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes
1976
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.
1982 Standout
DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas.
1980 StandoutNobel
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
Effects of nitrosoureas on human DNA polymerase activities from acute and chronic granulocytic leukemia cells
1976
Differential inhibition of the rejoining of X-ray-induced DNA strand breaks in normal and transformed human fibroblasts treated with 1,3-bis(2-chloroethyl)-1-nitrosourea in vitro.
1978 StandoutNobel
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
The role of protein kinase C in cell surface signal transduction and tumour promotion
1984 StandoutNature
Mechanisms of Cancer Drug Resistance
2002 Standout
Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases
1985
Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
1987 StandoutNobel
Cancer, Clinical Pharmacology, and Aging
1987
Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation.
1983 Standout
Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience.
1985
Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor
1987 Standout
A Critical Review of the Enrollment of Black Patients in Cancer Clinical Trials
2012
Treatment of the Newly Diagnosed Adult with De Noyo Acute Myeloid Leukemia
1993
Dexrazoxane-Associated Risk for Acute Myeloid Leukemia/Myelodysplastic Syndrome and Other Secondary Malignancies in Pediatric Hodgkin's Disease
2007
A Systematic Review of Barriers and Facilitators to Minority Research Participation Among African Americans, Latinos, Asian Americans, and Pacific Islanders
2013 Standout
Bone Marrow Transplant
1990 Standout
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
1984
Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials
2006
HOW NEUTROPHILS KILL MICROBES
2005 Standout
Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
1986
Therapy‐induced preleukaemia in patients treated for Hodgkin's lymphoma: clinical and therapeutic relevance of sequential chromosome banding studies
1984
Sensitization of frog erythrocyte adenylate cyclase system by tumor-promoting phorbol diesters
1985 StandoutNobel
Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia.
2002
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients
1984
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.
1987 StandoutNobel
Mechanistic Approaches to New Nitrosourea Development
1981 StandoutNobel
Chicken neutrophils: oxidative metabolism in phagocytic cells devoid of myeloperoxidase.
1975
A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study
1996
In vitro studies on the mode of action of the phorbol esters, potent tumor promoters: Part 1
1980
The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review
2015 Standout
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
1993
Soil compaction in cropping systems
2004 Standout
Works of Cooper Mr being referenced
Vincristine by continuous infusion in refractory breast cancer
1983
Phase I study of continuous infusion 6-thioguanine in patients with acute leukemia.
1995
Chemotherapy versus observation in high-risk node-negative breast cancer patients.
1992
Stimulation of oxidative metabolism in polymorphonuclear leukocytes by catecholamines.
1972
Study of methyl-CCNU(NSC-95441) in the treatment of lung cancer.
1974
A review of the clinical studies of alpha-interferon in the management of multiple myeloma.
1991
Pharmacokinetics of vincristine infusion.
1982
Acute lower respiratory tract infections in Calcutta children: An etiologic study.
1966
Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase.
1984
Community Clinical Oncology Program as a recruitment vehicle for cancer control research. The Southeast Cancer Control Consortium experience.
1995
Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study.
1982
Respiratory syncytial virus infection in children in West Bengal.
1971
Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies.
1985
Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules.
1986